Tocagen Inc Bonus & Incentive Agreements
10 Contracts & Agreements
- Amended and Restated 2021 Equity Incentive Plan (Filed With SEC on August 22, 2024)
- Amended and Restated 2021 Equity Incentive Plan, and forms of agreements thereunder (Filed With SEC on March 18, 2024)
- Amended and Restated 2021 Equity Incentive Plan (Filed With SEC on September 20, 2023)
- Forte Biosciences, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 31, 2022)
- Tocagen Inc. 2017 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on February 27, 2019)
- Tocagen Inc. 2017 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on November 8, 2018)
- Tocagen Inc. Annual Incentive Plan (Filed With SEC on August 9, 2017)
- TOCAGEN INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 31, 2017 APPROVED BY THE STOCKHOLDERS:MARCH 31, 2017 IPO DATE: (Filed With SEC on April 3, 2017)
- TOCAGEN INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: APPROVED BY THE STOCKHOLDERS: IPODATE: (Filed With SEC on March 9, 2017)
- TOCAGEN INC. 2009 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD: MARCH 23, 2009 APPROVED BY THE STOCKHOLDERS: MARCH 23, 2009 AMENDED BY THE BOARD: FEBRUARY 16, 2012 APPROVED BY THE... (Filed With SEC on March 9, 2017)
